Abstract
PurposeReputation risk onsets in focal firm whenever any entity of its supply chain (SC) faces risk-crisis event. A framework for modeling and predicting holistic SC reputation risk is proposed by integrating operational risk (OR) drivers originating from upstream and downstream partners and focal firm. A fuzzy cognitive map (FCM) is then developed to predict and quantify Pharmaceutical SC reputation risk.Design/methodology/approachUsing event study methodology, SC reputation risk framework with 13 input OR drivers was developed. Based on pharmaceutical supply chain experts’ opinion, the correlation between reputation risk and its input drivers was estimated. The developed FCM tool was validated using nine real-life instances. A series of “what-if” scenario analyses were performed to demonstrate effectiveness of proactive and reactive mitigation strategies against reputation risk.FindingsQuality and unethical governance risks significantly impacted reputation in Pharmaceutical SC and a firm should prefer “risk avoidance” against these risks. The upstream risks significantly affect reputation in a Pharmaceutical SC as compared to the downstream risks. Proactive mitigation strategies and assertive crisis communication are suggested for upstream risks while diminishment/ bolstering/rebuilding reactive crisis communication is recommended for downstream risks.Originality/valueReputation risk is often overlooked in SC literature. This work develops a model to quantify the reputation risk considering the indirect consequences of the ORs that originates at any point in a SC. The proposed FCM tool aids SC manager to focus on higher attribution risk events and devise an optimal combination of proactive and reactive mitigation strategies to avoid/minimize the economic loss due to reputation crisis.
Subject
General Business, Management and Accounting
Reference77 articles.
1. Fuzzy logic for modeling machining process: a review;Artificial Intelligence Review,2015
2. Organizational climate (OC) as employees' satisfier: empirical evidence from pharmaceutical sector;International Journal of Business and Management,2010
3. Allianz Risk Barometer (2020), available at: www.agcs.allianz.com/assets/PDFs/.../AllianzRiskBarometer2020.pdf (accessed February 2020).
4. Firms and collective reputation: the Volkswagen Emission Scandal as a case study (No. 6805),2017
5. The reputational effects of analysts' stock recommendations and credit ratings: evidence from operational risk announcements in the financial industry;International Review of Financial Analysis,2018
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献